Harry P Erba

20PUBLICATIONS
156CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyQuantum optics and quantum optomechanicsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 05, 2026
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

|Jun 02, 2026
Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia.

|Apr 08, 2026
Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.

Mark J Levis, Harry P Erba, Pau Montesinos

|Feb 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos

|Nov 24, 2025
Prognostic impact of age and MDS-associated mutations in NPM1 -mutated AML.

Vivian M Liu, Megan Othus, Jasmine Naru

|Oct 06, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trial.

Mark J Levis, Harry P Erba, Pau Montesinos

Pageof 4

Frequent Collaborators

11 joint publications

Mark R Litzow

6 joint publications

Anjali S Advani

5 joint publications

Richard F Little

4 joint publications

Paul M Barr